BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Procyon Corporation 

1150 Cleveland Street, Suite 410

Clearwater  Florida  33755  U.S.A.
Phone: n/a Fax:


SEARCH JOBS




Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Procyon Corporation Announces Amerx Healthcare Subsidiary Has Obtained #1 Ranking in Podiatry Management's 25th Annual Survey for Amerigel Wound & Skin Care Products 5/6/2008 11:09:33 AM
Procyon Corporation (OTCBB: PCYN) Reports Seventeenth Consecutive Profitable Quarter 10/1/2007 11:32:49 AM
Procyon Corporation Announces Receipt of Federal Supply Number With General Services Administration 7/23/2007 12:57:47 PM
Procyon Corporation (OTC-BB: PCYN) Reports Sixteenth Consecutive Profitable Quarter 5/24/2007 10:45:36 AM
Procyon Corporation (OTCBB: PCYN) Reports Fifteenth Consecutive Profitable Quarter 2/23/2007 11:17:31 AM
Procyon Corporation Presents Preclinical Results With Its Novel Tumor Vasculature Targeting Drug 2/7/2006 1:19:07 PM
Procyon BioPharma Inc. (PBP.TO) Reports Progress In Its U.S. Dose Finding Study For PCK3145 On Track To Complete Study By Year End 10/25/2005 11:54:30 AM
Procyon BioPharma Inc. (PBP.TO) Reports First Pharmacokinetic Results For Its HIV Protease Inhibitor, PPL-10010/19/2005 5:13:06 PM
Invitation To Participate In A Conference Call: Procyon BioPharma Inc. (PBP.TO) To Report The Receptor And Mode-Of-Action For PCK3145, Its Lead Drug Candidate For Advanced Metastatic Prostate Cancer10/19/2005 5:13:04 PM
Procyon Corporation Reports 2004 Year-End Results10/19/2005 5:12:52 PM
12